首页> 外文期刊>Statistics in medicine >Bayesian sample size for diagnostic test studies in the absence of a gold standard: Comparing identifiable with non-identifiable models.
【24h】

Bayesian sample size for diagnostic test studies in the absence of a gold standard: Comparing identifiable with non-identifiable models.

机译:在没有黄金标准的情况下用于诊断测试研究的贝叶斯样本量:将可识别模型与不可识别模型进行比较。

获取原文
获取原文并翻译 | 示例
           

摘要

Diagnostic tests rarely provide perfect results. The misclassification induced by imperfect sensitivities and specificities of diagnostic tests must be accounted for when planning prevalence studies or investigations into properties of new tests. The previous work has shown that applying a single imperfect test to estimate prevalence can often result in very large sample size requirements, and that sometimes even an infinite sample size is insufficient for precise estimation because the problem is non-identifiable. Adding a second test can sometimes reduce the sample size substantially, but infinite sample sizes can still occur as the problem remains non-identifiable. We investigate the further improvement possible when three diagnostic tests are to be applied. We first develop methods required for studies when three conditionally independent tests are available, using different Bayesian criteria. We then apply these criteria to prototypic scenarios, showing that large sample size reductions can occur compared to when only one or two tests are used. As the problem is now identifiable, infinite sample sizes cannot occur except in pathological situations. Finally, we relax the conditional independence assumption, demonstrating in this once again non-identifiable situation that sample sizes may substantially grow and possibly be infinite. We apply our methods to the planning of two infectious disease studies, the first designed to estimate the prevalence of Strongyloides infection, and the second relating to estimating the sensitivity of a new test for tuberculosis transmission. The much smaller sample sizes that are typically required when three as compared to one or two tests are used should encourage researchers to plan their studies using more than two diagnostic tests whenever possible. User-friendly software is available for both design and analysis stages greatly facilitating the use of these methods.
机译:诊断测试很少能提供理想的结果。在规划流行性研究或对新测试的属性进行调查时,必须考虑由于诊断测试的敏感性和特异性不完善而导致的分类错误。先前的工作表明,应用单个不完善的测试来估计患病率通常会导致非常大的样本量要求,并且有时甚至是无限的样本量也不足以进行精确估计,因为该问题无法识别。添加第二项测试有时可以大大减少样本数量,但是仍然存在无限的样本数量,因为问题仍然无法识别。我们将研究应用三个诊断测试时可能的进一步改进。当可以使用不同的贝叶斯标准进行三个条件独立的测试时,我们首先开发研究所需的方法。然后,我们将这些标准应用于原型场景,表明与仅使用一个或两个测试相比,可以减少大量样本。由于现在可以识别问题,因此除非出现病理情况,否则无法发生无限大的样本量。最后,我们放宽了条件独立性假设,再次证明了在这种无法确定的情况下样本量可能会大幅增长并且可能是无限的。我们将我们的方法应用于两项传染病研究的计划中,第一项旨在评估圆线虫感染的发生率,第二项与评估结核病传播新测试的敏感性有关。当使用三个测试而不是一个或两个测试时,通常需要的样本量要小得多,这应鼓励研究人员尽可能地使用两个以上的诊断测试来计划研究。用户友好的软件可用于设计和分析阶段,极大地方便了这些方法的使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号